Allogene Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1.72 M	96.7%	$2.90	+$5 M
Sells	3	-58.5 K	3.3%	$2.77	-$162 K
Net	-1	+1.67 M	93.4%		+$4.84 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Tpg Gp A, Llc	10%+ Owner	$59.4 M			Jan 12, 2022
David D. Chang	President and CEO, Director	$16.4 M			May 16, 2024
Arie Belldegrun	Director	$10.4 M	+$5 M	+92.4%	May 16, 2024
Eric Schmidt	Chief Financial Officer	$6.4 M			Mar 22, 2023
Geoffrey M. Parker	Chief Financial Officer	$3.38 M	+$683	+0.02%	May 16, 2024
Alison Moore	Chief Technical Officer	$2.14 M			Mar 22, 2023
Veer Bhavnagri	General Counsel	$1.77 M			Mar 14, 2023
Rafael Amado	EVP of R&D	$1.72 M			Oct 7, 2022
Zachary Roberts	EVP of R&D	$1.64 M			Jan 25, 2024
Earl Douglas	SVP, General Counsel	$1.52 M			Jan 25, 2024
N. Witte	Director	$930 K			Jun 5, 2024
Timothy L. Moore	Chief Technical Officer	$920 K			Apr 22, 2024
Franz B. Humer	Director	$740 K	-$26.2 K	-3.42%	Jun 5, 2024
Lillian Smith	VP, Corporate Counsel	$446 K			Apr 1, 2023
Deborah M. Messemer	Director	$380 K	-$92.8 K	-19.6%	Jun 18, 2024
Vicki Sato	Director	$380 K			Jun 5, 2024
Yinlin Jack Chen	SVP, Finance	$282 K			Aug 10, 2023
Annie Yoshiyama	SVP, Finance	$238 K			Jun 5, 2024
Stephen Mayo	Director	$80.4 K	-$42.9 K	-34.8%	Jun 5, 2024
PF Equity Holdings 2 B.V.	10%+ Owner				Mar 31, 2022
Elizabeth Barrett	Director				Jun 5, 2024
Joshua A. Kazam	Director				Jun 5, 2024

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership